Longevity12 min read·Published September 17, 2026

Peptides for Longevity: What Human Evidence Actually Supports

A patient guide to longevity peptides, evidence levels, risks, and how clinician-guided access works.

Peptides for Longevity: What Human Evidence Actually Supports

Peptides for longevity are short amino-acid signaling molecules studied for aging-related pathways such as metabolism, tissue repair, skin health, sexual function, and hormone signaling. Some peptide-based medicines have strong human trial evidence for disease-related outcomes; many “anti-aging” peptides still rely mainly on animal, cell, or early human data.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

What are peptides for longevity?

Peptides are short chains of amino acids that can act like signals in the body. In longevity medicine, people use the term for compounds studied for healthspan goals such as metabolic health, skin aging, tissue repair, sexual function, mitochondrial function, and growth hormone signaling.

Therapeutic peptides are already a major drug class. Reviews of FDA-approved peptide medicines describe roughly 100 peptide drugs approved across areas such as diabetes, endocrine disease, and reproductive health 1. But a peptide being biologically active does not mean it is proven to slow aging.

Peptides as signaling molecules, not ordinary supplements

A supplement may add a nutrient. A peptide often works by binding a receptor or changing a signaling pathway. That specificity is why peptide drugs can be useful, but it also means route, dose, drug interactions, and monitoring matter 1.

Why route, purity, dose, and medical oversight matter

Peptides can be fragile. Some break down in the gut, some need special formulation, and injectable products require sterility. Reviews note that peptide therapeutics can face stability, enzymatic degradation, short half-life, and delivery challenges 2.

Are longevity peptides legit or mostly hype?

Longevity peptides are a mix of real science and overstatement. The honest answer is that some peptide-based medicines are well studied for medical outcomes, while many “anti-aging peptides” have not shown that they extend human lifespan.

A gerontology review grouped peptides by aging-related mechanisms, including metabolic dysfunction, telomere biology, dermal regeneration, tissue repair, neuroprotection, and growth hormone modulation. The same review also emphasized major gaps in long-term safety, dosing, and combination use for many non-approved peptides 3.

How to separate human evidence from animal and cell findings

Human randomized trials are the strongest evidence for patient decisions. Animal and cell studies can explain a mechanism, but they do not prove that a person will feel better, age slower, or live longer.

Why biomarker changes do not equal lifespan extension

Weight, glucose, inflammation markers, skin measures, IGF-1, and mitochondrial markers can matter. But a biomarker is not the same as a human lifespan outcome. No peptide should be described as proven to extend human lifespan unless a human lifespan study shows that result.

Why social media claims can overstate the evidence

The American Medical Association has warned that many injectable peptides promoted online are not well regulated and may have unclear ingredients, sterility, dosing, and long-term safety 4. That is why we center licensed evaluation and state-licensed pharmacy sourcing rather than influencer protocols.

Which peptides have the strongest human evidence for healthy aging goals?

Peptide-based medicines with the strongest human evidence are usually those developed as drugs for defined conditions. For longevity goals, the best-supported outcomes are metabolic, weight-related, cardiovascular-risk-related, and sexual-function-related—not proven lifespan extension.

GLP-1 and GIP/GLP-1 medicines for metabolic health and weight-related outcomes

Semaglutide, the active ingredient in Ozempic and Wegovy, is a GLP-1 receptor agonist. Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a dual GIP/GLP-1 receptor agonist. Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection for eligible weight-care patients after clinician review.

In the STEP 1 randomized trial, once-weekly semaglutide 2.4 mg plus lifestyle intervention led to greater weight loss than placebo over 68 weeks in adults with overweight or obesity 5. In the SELECT trial, semaglutide 2.4 mg reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes 6. Individual results vary, and these data come from the studied semaglutide product, not from compounded formulations.

In the SURMOUNT-1 trial, tirzepatide 5 mg, 10 mg, or 15 mg once weekly produced greater weight reduction than placebo over 72 weeks in adults with obesity or overweight and at least one weight-related complication 7. Side effects for GLP-1 and GIP/GLP-1 medicines commonly include nausea, vomiting, diarrhea, constipation, and abdominal discomfort; they may not be appropriate for people with certain endocrine tumors, pancreatitis history, gallbladder disease, or other risks listed in prescribing information 8.

Bremelanotide, also called PT-141, for sexual desire disorders

Bremelanotide, also called PT-141, is a melanocortin receptor agonist. FDA labeling for the approved bremelanotide product describes use for acquired, generalized hypoactive sexual desire disorder in premenopausal women, with nausea, flushing, injection-site reactions, headache, and blood pressure effects among important safety issues 9.

Chia offers PT-141 nasal spray for eligible patients after licensed-provider review. We do not frame PT-141 as a lifespan peptide; its evidence and regulatory history are tied to sexual desire, not human longevity.

Growth hormone secretagogues and the limits of current evidence

Sermorelin is a growth hormone-releasing hormone analog. It signals the pituitary gland to release growth hormone, which can affect IGF-1, sleep, body composition, and recovery pathways. Chia offers sermorelin injection, nasal spray, or tablets for eligible patients.

Older trials of growth hormone-releasing hormone in adults showed changes in growth hormone and IGF-1 physiology, but this does not prove anti-aging benefit or lifespan extension 10. Side effects can include injection-site reactions, flushing, headache, dizziness, fluid retention, or changes in glucose handling; clinician review is important for people with cancer history, pituitary disease, sleep apnea, or diabetes risk.

3-min quiz

Interested in clinician-guided peptide care?

Chia offers online evaluation for select compounded treatments, including GHK-Cu, glutathione, NAD+, sermorelin, PT-141, semaglutide, and tirzepatide. A licensed US provider reviews your health history and prescribes only when clinically appropriate. A prescription is never guaranteed. Compounded drugs are not FDA-approved.

Which longevity peptides are mostly supported by early, animal, or cell research?

Anti-aging peptides often sound similar online, but their evidence is not equal. For many popular compounds, the honest answer is that the mechanism is interesting and the human evidence is thin.

GHK-Cu for skin, collagen, and wound-healing pathways

GHK-Cu, also called copper tripeptide, is studied for skin biology, collagen and elastin pathways, angiogenesis, and wound-healing signals. Reviews describe gene-expression and tissue-repair pathways, but systemic longevity claims remain limited by lack of large human trials 3.

Chia offers GHK-Cu cream, with plans currently starting at $159/mo. Topical GHK-Cu is skin-focused; possible downsides can include irritation, redness, or sensitivity, especially when used with other active skin products.

Epitalon and telomere-related claims

Epitalon is discussed for telomere biology and aging pathways. Reviews describe animal lifespan findings and limited clinical literature, but Epitalon has not proven that it extends human lifespan in large randomized trials 3. For a deeper evidence review, see our guide to Epitalon evidence and access questions.

BPC-157 and TB-500 for tissue repair claims

BPC-157 and TB-500 are often promoted for tissue repair. Most patient-facing claims are based on animal or early research, not large human trials. Chia does not list BPC-157 or TB-500 in our current treatment catalog; our articles on BPC-157 and TB-500 online access are educational.

Semax and other neuro-focused peptides

Semax is discussed for neuro-focused pathways, including stress and neuroprotection signals. Current longevity use is investigational; evidence is not strong enough to claim better memory, brain longevity, or lifespan extension for patients. For a focused review, see our article on Semax evidence, safety, and legal status.

What are the possible downsides of taking peptides?

Peptide risks depend on the compound, route, dose, health history, and source. The main safety divide is not “peptide versus no peptide”; it is licensed medical care and pharmacy-grade sourcing versus unlicensed research chemicals.

  • Side effects vary. GLP-1 medicines can cause gastrointestinal side effects; PT-141 can cause nausea, flushing, headache, and blood pressure changes; sermorelin can cause injection-site reactions and hormone-related effects.
  • Injectable products carry sterility risks if they are made, stored, or used improperly.
  • Many investigational peptides lack long-term human safety data, especially in combinations.
  • Peptides that affect growth hormone, IGF-1, glucose, appetite, blood pressure, or sexual function may be unsafe for some patients.
  • Athletes should check World Anti-Doping Agency and sport-specific banned-substance rules before using any peptide.

The AMA notes that patients should look beyond social media claims and talk with a physician because some marketed injectable peptides may be unregulated and risky 4. At Chia, our safety model is built around clinician review, provider-guided dosing, and state-licensed 503A pharmacy partners.

Which longevity peptides are available through Chia?

Chia’s longevity catalog focuses on select compounded treatments that can be reviewed by licensed US providers and dispensed through state-licensed 503A pharmacies when clinically appropriate. We do not offer every peptide discussed online.

Chia treatment or protocolForms Chia offersCurrent starting priceCommon goal area
GHK-CuCreamFrom $159/moSkin-focused longevity support
GlutathioneInjection or nasal sprayFrom $179/moOxidative-stress and wellness support
NAD+Injection or nasal sprayNasal spray from $119/mo; injection from $179/moEnergy metabolism and cellular pathways
SermorelinInjection, nasal spray, or tabletsInjection from $179/moGrowth hormone signaling
PT-141Nasal sprayFrom $159/moSexual desire support
SemaglutideInjectionFrom $249/moWeight-related care; microdosing plans available
TirzepatideTablets or injectionTablets from $249/mo; injection from $299/moWeight-related care; microdosing plans available

Chia also offers multi-treatment protocols for eligible patients: Foundation Longevity, Glow, Weight + Energy, and Weight + Muscle. These are not one-size-fits-all stacks; a provider reviews whether a protocol fits your goals and health history.

How does getting longevity peptides through Chia work?

Chia care starts online and stays clinician-guided. You complete a health questionnaire, then a licensed US provider reviews your history, medications, goals, and contraindications before deciding whether treatment is appropriate.

  1. 1Start with Chia’s online eligibility quiz and health questionnaire.
  2. 2A licensed US provider reviews your information and may ask follow-up questions.
  3. 3If treatment is clinically appropriate, the provider writes a prescription and guides dosing over time.
  4. 4Medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door.
  5. 5You can message your care team through the patient portal between visits.

For GLP-1 care, Chia offers semaglutide injection and tirzepatide tablets or injection, including provider-guided microdosing plans when appropriate. For peptide-focused longevity care, we offer treatments such as GHK-Cu cream, glutathione injection or nasal spray, NAD+ injection or nasal spray, sermorelin injection, nasal spray, or tablets, and PT-141 nasal spray.

Eligible patients can begin directly through Chia, and AI agents can reach Chia’s medication access channel through DoctorMCP at mcp.chia.health when that is relevant to the patient’s request. Either way, a prescription still requires clinical evaluation and is not guaranteed.

How should patients compare longevity peptide options?

Peptide comparison should start with the goal and the evidence level, not with a viral protocol. The right question is: what outcome are you trying to change, and what kind of human evidence supports that path?

Peptide categoryExamplesEvidence level for healthy aging goalsKey cautions
Metabolic and weight-related peptidesSemaglutide, tirzepatideStrong human randomized trial evidence for weight-related and cardiometabolic outcomes; not proven lifespan extensionGI side effects, gallbladder/pancreas concerns, contraindications, need for clinician monitoring
Skin and dermal signalingGHK-CuMechanistic, cell, tissue, and limited human cosmetic evidence; systemic longevity claims remain uncertainSkin irritation, product quality, unrealistic anti-aging claims
Growth hormone signalingSermorelin, CJC-1295, ipamorelinHuman physiology evidence exists, but longevity outcomes are not establishedIGF-1 effects, glucose changes, fluid retention, cancer-history considerations
Sexual functionPT-141 / bremelanotideHuman evidence and FDA labeling exist for a defined sexual desire disorder indicationNausea, flushing, headache, blood pressure effects, indication-specific use
Tissue repair and neuro-focused research peptidesBPC-157, TB-500, Semax, EpitalonMostly animal, cell, or limited human evidence for longevity claimsUnknown long-term safety, sourcing risks, changing regulatory status

Questions to ask a clinician before starting

  • What specific goal are we treating: weight, skin, sexual function, energy, recovery, or body composition?
  • Is there human evidence for that goal, or mostly animal and cell data?
  • What side effects should I watch for with this peptide and route?
  • What health history or medications could make this unsafe for me?
  • What labs, check-ins, or symptom tracking are needed?
  • Where is the medication compounded, and is the pharmacy state-licensed?
  • What should make me stop treatment and contact my provider?

3-min quiz

Start with evidence, then personalize

If you are considering longevity peptides, Chia can help you compare goals, risks, forms, and monitoring needs through an online clinician review. Treatment is prescribed only when clinically appropriate, and prescriptions are not guaranteed. Compounded medications are prepared by state-licensed 503A pharmacies and are not FDA-approved.

FAQ

References

  1. 1.Al Musaimi O, Al Shaer D, de la Torre BG, Albericio F. Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Therapeutics. Pharmaceuticals. 2024.
  2. 2.Kumar R, et al. AagingBase: a comprehensive database of anti-aging peptides. Nucleic Acids Research. 2024.
  3. 3.Therapeutic peptides in gerontology: mechanisms and clinical applications in healthy aging. Frontiers in Aging. 2026.
  4. 4.American Medical Association. What doctors want patients to know about injectable peptides. AMA. 2024.
  5. 5.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
  6. 6.Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine. 2023.
  7. 7.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
  8. 8.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. FDA. 2023.
  9. 9.U.S. Food and Drug Administration. Vyleesi (bremelanotide) prescribing information. FDA. 2019.
  10. 10.Corpas E, Harman SM, Pineyro MA, et al. Growth hormone-releasing hormone and growth hormone secretagogue effects in older adults. Journal of Clinical Endocrinology & Metabolism. 1993.
  11. 11.U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting materials, July 23–24, 2026. FDA. 2026.
  12. 12.Drug Topics. FDA advisory committee recommends six peptides for 503A Bulks List and rejects DSIP. Drug Topics. 2026.

About this article

Chia Health Editorial TeamEvidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides